Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check2 days agoChange DetectedThe site’s displayed revision number changes from v3.8.0 to v3.8.1; the clinical trial record remains unchanged.SummaryDifference0.1%

- Check9 days agoChange DetectedThe clinical trial record for the FG-4592 and rosiglitazone interaction study is displayed, including its participant criteria, study plan, outcome measures, and history. The record also lists roxadustat as a related MeSH term.SummaryDifference29%

- Check16 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedAn NIH notice about terminology changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record itself remains inaccessible.SummaryDifference1%

- Check44 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-restricted message. This prevents viewing the trial record and related navigation on the page.SummaryDifference14%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.